$2.05
-0.03-1.44%
At close: Dec 16, 4:00 PM EST
Comments
Loading...
Apimeds Pharmaceuticals Earnings Estimates, EPS & Revenue | AMEX:APUS | Benzinga
Apimeds Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-0.140
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Apimeds Pharmaceuticals using advanced sorting and filters.
Apimeds Pharmaceuticals (APUS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Apimeds Pharmaceuticals (APUS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Apimeds Pharmaceuticals (AMEX:APUS) reporting earnings?
Apimeds Pharmaceuticals (APUS) is scheduled to report earnings on February 22, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for Apimeds Pharmaceuticals (AMEX:APUS)?
The Actual EPS was $-0.14, which missed the estimate of $0.00.
What were Apimeds Pharmaceuticals’s (AMEX:APUS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
